A1c Test with Reflex to 1,5-Anhydroglucitol

The A1c Test with Reflex to 1,5-Anhydroglucitol measures hemoglobin A1c to evaluate average blood sugar over the past 2 to 3 months. When A1c falls within the reflex range of 6.5% to 8.0%, 1,5-AG may be added to provide additional insight into recent glucose patterns, intermediate glycemic control, and possible short-term glucose fluctuations that may not be fully reflected by A1c alone. This test supports a more complete view of glycemic trends.

Blood
Phlebotomist
There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

HEMOGLOBIN A1C

The A1c test evaluates the average amount of glucose in the blood over the last 2 to 3 months. It does this by measuring the concentration of glycated (also often called glycosylated) hemoglobin A1c. Hemoglobin is an oxygen-transporting protein found inside red blood cells (RBCs). There are several types of normal hemoglobin, but the predominant form – about 95-98% – is hemoglobin A. As glucose circulates in the blood, some of it spontaneously binds to hemoglobin A. The hemoglobin molecules with attached glucose are called glycated hemoglobin. The higher the concentration of glucose in the blood, the more glycated hemoglobin is formed. Once the glucose binds to the hemoglobin, it remains there for the life of the red blood cell – normally about 120 days. The predominant form of glycated hemoglobin is referred to as HbA1c or A1c. A1c is produced on a daily basis and slowly cleared from the blood as older RBCs die and younger RBCs (with non-glycated hemoglobin) take their place. This test is used to monitor treatment in someone who has been diagnosed with diabetes. It helps to evaluate how well their glucose levels have been controlled by treatment over time. This test may be used to screen for and diagnose diabetes or risk of developing diabetes. In 2010, clinical practice guidelines from the American Diabetes Association (ADA) stated that A1c may be added to fasting plasma glucose (FPG) and oral glucose tolerance test (OGTT) as an option for diabetes screening and diagnosis. For monitoring purposes, an A1c of less than 7% indicates good glucose control and a lower risk of diabetic complications for the majority of diabetics. However, in 2012, the ADA and the European Association for the Study of Diabetes (EASD) issued a position statement recommending that the management of glucose control in type 2 diabetes be more "patient-centered." Data from recent studies have shown that low blood sugar (hypoglycemia) can cause complications and that people with risk of severe hypoglycemia, underlying health conditions, complications, and a limited life expectancy do not necessarily benefit from having a stringent goal of less than 7% for their A1c. The statement recommends that people work closely with their doctor to select a goal that reflects each person's individual health status and that balances risks and benefits.
*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The A1c Test with Reflex to 1,5-Anhydroglucitol test contains 1 test with 1 biomarker .

If Hemoglobin A1c is ≥6.5% and ≤8.0%, then 1,5-Anhydroglucitol (1,5-AG), Intermediate Glycemic Control will be performed at an additional charge.

The A1c Test with Reflex to 1,5-Anhydroglucitol is a blood test that measures Hemoglobin A1c, a key marker used to evaluate average blood sugar levels over the previous 2 to 3 months. Hemoglobin A1c, often written as HbA1c or A1c, reflects the percentage of hemoglobin proteins in red blood cells that have glucose attached to them. Because red blood cells circulate for approximately several months, A1c provides a longer-term picture of glycemic control than a single fasting glucose or random glucose result.
This test also includes a reflex component. The primary test performed is Hemoglobin A1c. If the Hemoglobin A1c result is greater than or equal to 6.5% and less than or equal to 8.0%, then 1,5-Anhydroglucitol, also known as 1,5-AG, Intermediate Glycemic Control, will be performed at an additional charge. This reflex design allows the A1c result to determine whether additional testing may provide more information about recent glycemic patterns. A1c is useful for assessing overall glucose exposure, while 1,5-AG can add insight into shorter-term glucose fluctuations that may occur over a more recent time frame.
This type of reflex testing may be helpful when a person’s A1c result falls within a range where additional information about intermediate glycemic control may support a more complete understanding of blood sugar patterns. While A1c is widely used for diabetes screening, diabetes monitoring, and long-term glucose assessment, it may not fully show recent glucose variability or short-term post-meal glucose elevations. In that context, 1,5-AG may provide complementary information.
The A1c Test with Reflex to 1,5-Anhydroglucitol is an educational and clinically useful laboratory option for evaluating glycemic status. Results should be interpreted in context with medical history, symptoms, medications, glucose readings, and other laboratory findings. This test does not replace medical evaluation, but it can help support informed discussions about blood sugar control, diabetes risk, and ongoing glucose management.

When and Why Someone Would Order This Test

Common Reasons for Testing

The A1c Test with Reflex to 1,5-Anhydroglucitol may be ordered when there is a need to evaluate average blood sugar levels, assess diabetes risk, monitor known glycemic concerns, or better understand how glucose levels have been trending over time. Hemoglobin A1c is one of the most commonly used laboratory markers for evaluating long-term glucose control because it reflects average blood sugar exposure over the previous 2 to 3 months. This makes it useful for individuals who want a broader view of their glucose status rather than relying only on a single blood glucose measurement.
Someone may consider this test if they have risk factors associated with abnormal glucose metabolism, such as a family history of diabetes, excess body weight, history of gestational diabetes, sedentary lifestyle, high blood pressure, abnormal cholesterol levels, or previous borderline glucose results. It may also be considered when symptoms such as increased thirst, frequent urination, fatigue, blurred vision, or unexplained changes in weight raise concern for possible glucose imbalance. These symptoms can occur for many reasons, so testing is used as one part of a broader evaluation.
This test may also be useful for people already monitoring blood sugar patterns. A1c can help evaluate whether overall glucose control has remained stable or changed over time. Because this test includes reflex testing, it may provide added information when the A1c result falls between 6.5% and 8.0%. In that range, 1,5-AG may help evaluate more recent glycemic control, especially short-term glucose elevations that may not be obvious from A1c alone.
Healthcare providers may use this test when they want a structured approach that begins with A1c and only adds 1,5-AG when the specified reflex criteria are met. This can be helpful when evaluating glucose control in a patient whose A1c suggests diabetes-range or moderately elevated glycemic patterns. The additional 1,5-AG result may support a more detailed discussion about recent glucose variability, post-meal glucose patterns, and whether current management strategies are meeting the patient’s needs. As with all laboratory testing, results should be reviewed with a qualified healthcare professional who can interpret the findings in the context of the full clinical picture.

What Does the Test Measure

Hemoglobin A1c and Reflex 1,5-Anhydroglucitol

The primary biomarker measured by this test is Hemoglobin A1c. Hemoglobin is a protein in red blood cells that carries oxygen throughout the body. When glucose circulates in the bloodstream, some of it attaches to hemoglobin through a process called glycation. The A1c result reports the percentage of hemoglobin that has glucose attached. Higher A1c values generally reflect higher average blood sugar levels over time, while lower values generally reflect lower average blood sugar exposure.
A1c is different from a fasting glucose test because it is not limited to the blood sugar level at the moment the blood sample is collected. Instead, it provides a longer-term estimate of glycemic exposure. This is why A1c is commonly used to screen for prediabetes and diabetes, monitor glycemic control in people with diabetes, and assess whether glucose patterns are changing.
The reflex portion of this test involves 1,5-Anhydroglucitol, also called 1,5-AG, Intermediate Glycemic Control. This biomarker is only performed when the Hemoglobin A1c result is greater than or equal to 6.5% and less than or equal to 8.0%. 1,5-AG is a naturally occurring substance in the blood that can decrease when glucose levels rise above the kidney’s ability to reabsorb glucose efficiently. Because of this relationship, lower 1,5-AG levels may be associated with recent episodes of elevated glucose, particularly short-term or post-meal glucose excursions.
The combination of A1c and reflex 1,5-AG can provide two related but different views of glycemic status. A1c reflects average glucose over a longer period, while 1,5-AG may add insight into more recent glycemic patterns. This is important because two people can have similar A1c results but different day-to-day glucose patterns. One person may have stable glucose levels, while another may have frequent spikes and drops that average out to a similar A1c. When reflex criteria are met, 1,5-AG may help provide additional context about intermediate glycemic control and recent glucose variability.

How Patients and Healthcare Providers Use the Results

Interpreting Results in Clinical Context

Results from the A1c Test with Reflex to 1,5-Anhydroglucitol can help patients and healthcare providers evaluate blood sugar patterns, identify possible glucose abnormalities, and guide conversations about prevention, diagnosis, monitoring, and treatment planning. Hemoglobin A1c is commonly used to help assess whether a person’s blood sugar levels fall within a normal, prediabetes, or diabetes range. A1c results may also be used to monitor how well glucose management strategies are working over time.
For individuals without a previous diagnosis of diabetes, an A1c result can provide important screening information. A result below 5.7% is generally considered within the normal range, 5.7% to 6.4% is generally considered consistent with prediabetes, and 6.5% or higher is generally in the diabetes range. A diagnosis should not be based on a single number without proper clinical interpretation. Healthcare providers may consider repeat testing, symptoms, medical history, additional glucose testing, and other factors before making a diagnosis or recommending next steps.
For individuals with diabetes or ongoing glucose concerns, A1c results can help evaluate long-term glycemic control. Providers may compare current results with previous results to see whether blood sugar patterns are improving, worsening, or remaining stable. This can help guide discussions about nutrition, physical activity, medication plans, weight management, glucose monitoring, and risk reduction. A1c is also relevant because long-term elevated glucose can contribute to complications affecting the heart, blood vessels, kidneys, eyes, and nerves.
When the reflex criteria are met and 1,5-AG is performed, the added result may help identify recent glucose elevations that may not be fully captured by A1c alone. This may be useful when A1c is moderately elevated or when there is concern that average glucose does not fully reflect short-term glycemic variability. A 1,5-AG result may support conversations about post-meal blood sugar patterns, timing of glucose elevations, dietary response, medication effectiveness, or whether additional monitoring may be appropriate.
Patients can use the results as a starting point for informed discussions with their healthcare provider. The test may help clarify whether glucose patterns are within expected ranges, whether additional testing is needed, and whether lifestyle or treatment adjustments should be considered. Results are most useful when reviewed alongside the patient’s full health history and current care plan.

Understanding the Value of A1c and Reflex Glycemic Testing

The A1c Test with Reflex to 1,5-Anhydroglucitol provides a structured way to evaluate both longer-term and, when indicated, more recent blood sugar patterns. Hemoglobin A1c is one of the most widely recognized markers for assessing average glucose exposure over time. It can help identify patterns consistent with normal glycemic control, prediabetes, or diabetes-range results, and it can also support ongoing monitoring for individuals already working with a healthcare provider on blood sugar management.
The reflex design adds another layer of information when the A1c result falls within the specified range of 6.5% to 8.0%. In those cases, 1,5-AG, Intermediate Glycemic Control, may be performed at an additional charge. This biomarker can help provide a shorter-term view of glycemic control, especially when recent glucose fluctuations or post-meal elevations may be clinically relevant. By combining the broader perspective of A1c with the potential short-term insight of 1,5-AG, this test may support a more complete evaluation of glucose trends.
Understanding blood sugar patterns is important because glucose regulation affects many areas of health. Persistent elevations in blood sugar can be associated with diabetes and may increase the risk of long-term complications if not properly addressed. At the same time, laboratory results should always be interpreted carefully. A1c can be influenced by certain medical conditions, changes in red blood cell turnover, hemoglobin variants, pregnancy, kidney disease, recent blood loss, and other factors. This is why a healthcare provider’s interpretation is essential.
This test is best viewed as part of a broader approach to metabolic health and glycemic assessment. It can provide useful information, but it does not determine the full picture by itself. Follow-up may include additional laboratory testing, home glucose monitoring, continuous glucose monitoring, nutrition review, medication review, or other clinical evaluation depending on the individual situation.
For patients and healthcare providers, the A1c Test with Reflex to 1,5-Anhydroglucitol offers meaningful information that can support clearer conversations about glucose control. Whether used for screening, monitoring, or follow-up evaluation, it helps translate blood sugar patterns into actionable clinical context while keeping interpretation grounded in the patient’s overall health profile.

Customer Reviews